As the program engages more directly with global concerns such as the climate crisis, he will lead the way.
T-cell engager (TCE) specialist Candid Therapeutics has entered a reverse merger agreement with Rallybio that will allow Candid to trade on the Nasdaq while dumping RallyBio’s rare disease maternal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results